Cancer of Unknown Primary Site Active Not Recruiting Phase 2 Trials for Sintilimab (DB15765)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0089665 (Cancer of Unknown Primary Site) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05024968 | Sintilimab in Cancer of Unknown Primary | Treatment |